Skip to main content

Table 3 Comparison of subgroups by our definitions between GBS patients with and without elevated CK levels

From: Clinical features of Guillain–Barré syndrome patients with elevated serum creatine kinase levels

 

GBS patients with elevated CK levels

(n = 14)

GBS patients with normal CK levels

(n = 37)

P-value

AIDP

0 (0)

15 (41)

0.005

AMAN

14 (100)

22 (59)

0.005

 AMAN with axonal degeneration

3 (21)

5 (14)

NS

 AMAN with RCF

11 (79)

17 (46)

NS

  1. Abbreviations: GBS Guillain–Barré syndrome, CK Creatine kinase, AIDP Acute inflammatory demyelinating polyneuropathy, AMAN Acute motor axonal neuropathy, RCF Reversible conduction failure, NS Not significant